TIAA CREF INVESTMENT MANAGEMENT LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 177 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q1 2019$9,462,000
+66.4%
136,413
+4.3%
0.01%
+40.0%
Q4 2018$5,687,000
-74.5%
130,794
-55.2%
0.01%
-28.6%
Q3 2018$22,278,000
+58.2%
291,820
+59.3%
0.01%
-22.2%
Q2 2018$14,082,000
+41.0%
183,198
-6.5%
0.01%
+28.6%
Q1 2018$9,987,000
+53.9%
195,859
+40.0%
0.01%
+75.0%
Q4 2017$6,490,000
+4.7%
139,938
+20.3%
0.00%0.0%
Q3 2017$6,197,000
-16.0%
116,349
-2.0%
0.00%
-20.0%
Q2 2017$7,373,000
-20.5%
118,703
-13.3%
0.01%
-28.6%
Q1 2017$9,277,000
-8.2%
136,873
-4.8%
0.01%
-12.5%
Q4 2016$10,106,000
-5.1%
143,731
-4.2%
0.01%
+14.3%
Q3 2016$10,644,000
+42.5%
150,044
-1.7%
0.01%
+16.7%
Q2 2016$7,467,000
-25.4%
152,665
-3.5%
0.01%
-25.0%
Q1 2016$10,011,000
-43.9%
158,133
-0.6%
0.01%
-38.5%
Q4 2015$17,842,000
+16.8%
159,052
+0.3%
0.01%
+8.3%
Q3 2015$15,277,000
+105.9%
158,620
+118.9%
0.01%
+140.0%
Q2 2015$7,420,000
+251.0%
72,466
+112.8%
0.01%
+400.0%
Q1 2015$2,114,000
+41.5%
34,0550.0%0.00%0.0%
Q4 2014$1,494,000
-20.9%
34,055
+2.1%
0.00%0.0%
Q3 2014$1,888,000
+63.6%
33,356
+29.8%
0.00%0.0%
Q2 2014$1,154,000
-2.5%
25,702
+6.2%
0.00%0.0%
Q1 2014$1,183,00024,1970.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q4 2016
NameSharesValueWeighting ↓
Abingworth LLP 38,100$2,928,0001.67%
Opaleye Management Inc. 80,000$6,149,0001.59%
HIGHLINE CAPITAL MANAGEMENT, L.P. 410,000$31,517,0001.06%
Opus Point Partners Management, LLC 6,311$485,0001.05%
SECTOR GAMMA AS 68,015$5,228,0000.87%
Capital Impact Advisors, LLC 27,074$2,061,0000.76%
FORTALEZA ASSET MANAGEMENT INC/ 1,130$87,0000.71%
CAPITAL INTERNATIONAL LTD /CA/ 46,957$3,610,0000.63%
Virtus ETF Advisers LLC 8,794$676,0000.60%
Rock Springs Capital Management LP 200,000$15,374,0000.59%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders